Skip to main content
. 2018 Oct 29;5:47. doi: 10.1186/s40634-018-0162-4

Fig. 1.

Fig. 1

In Vitro quantitative assessment. aInitial PRP concentration in the samples (t = 0), in the presence of Visipaque270® and Iopamiron200®. b Evolution of PRP ratio as a function of time (5 incubation delays: 5, 10, 15, 20, 30mn), for each contrast agent group (Visipaque270® and Iopamiron200®). c Morphological aspect of platelets before and after exposure to iodine contrast agent: no change was seen